Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
enVVeno Medical Corp
NVNOCurrent price
3.4 USD
-0.08 USD (-2.30%)
Last closed
3.49 USD
Company
www.envveno.com
ISIN
US29415J1060
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
61 551 360 USD
Yield for 12 month
-25.44 %
1Y
3Y
5Y
10Y
15Y
NVNO
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Address: 70 Doppler, Irvine, CA, United States, 92618
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
18 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-546 000 USD
Last Year
-525 000 USD
Current Quarter
-129 000 USD
Last Quarter
-136 000 USD
Key Figures NVNO
1 year
3 years
5 years
10 years
EBITDA
-23 201 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.28 %
PEG Ratio
–
Return On Equity TTM
-58.77 %
Wall Street Target Price
18 USD
Revenue TTM
–
Book Value
2.7 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.29 USD
Diluted Eps TTM
-1.29 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NVNO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NVNO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
30.11.2020
Dividend Date
30.11.2020
Stock Valuation NVNO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.8684
Price Book MRQ
1.2994
Financials NVNO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NVNO
For 52 weeks
3.01 USD
6.97 USD
50 Day MA
3.98 USD
Shares Short Prior Month
762 788
200 Day MA
4.92 USD
Short Ratio
2.31
Shares Short
549 079
Short Percent
3.14 %
BeatStart